Microbot Medical Inc - Asset Resilience Ratio
Microbot Medical Inc (MBOT) has an Asset Resilience Ratio of 88.19% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2025)
This chart shows how Microbot Medical Inc's Asset Resilience Ratio has changed over time. Check Microbot Medical Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Microbot Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MBOT market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $68.84 Million | 88.19% |
| Total Liquid Assets | $68.84 Million | 88.19% |
Asset Resilience Insights
- Very High Liquidity: Microbot Medical Inc maintains exceptional liquid asset reserves at 88.19% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Microbot Medical Inc Industry Peers by Asset Resilience Ratio
Compare Microbot Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.46% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Microbot Medical Inc (1998–2025)
The table below shows the annual Asset Resilience Ratio data for Microbot Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 91.58% | $74.68 Million | $81.54 Million | +52.52pp |
| 2024-12-31 | 39.06% | $2.36 Million | $6.03 Million | -7.97pp |
| 2023-12-31 | 47.04% | $3.92 Million | $8.33 Million | -13.36pp |
| 2022-12-31 | 60.40% | $5.76 Million | $9.54 Million | +48.47pp |
| 2021-12-31 | 11.92% | $2.00 Million | $16.77 Million | -7.10pp |
| 2020-12-31 | 19.02% | $5.00 Million | $26.28 Million | +12.23pp |
| 2019-12-31 | 6.79% | $2.52 Million | $37.13 Million | +6.55pp |
| 2017-12-31 | 0.25% | $27.00K | $11.02 Million | -14.75pp |
| 2016-12-31 | 14.99% | $505.00K | $3.37 Million | +70.01pp |
| 2015-12-31 | -55.02% | $-11.67 Million | $21.22 Million | -55.02pp |
| 2014-12-31 | 0.00% | $-397.00 | $32.43 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $41.56 Million | -- |
| 2012-12-31 | 46.07% | $13.90 Million | $30.17 Million | +33.06pp |
| 2011-12-31 | 13.02% | $3.28 Million | $25.21 Million | +12.39pp |
| 2010-12-31 | 0.62% | $190.80K | $30.60 Million | +0.24pp |
| 2009-12-31 | 0.38% | $197.00K | $51.19 Million | -9.76pp |
| 2008-12-31 | 10.14% | $4.18 Million | $41.23 Million | -45.15pp |
| 2007-12-31 | 55.29% | $26.70 Million | $48.28 Million | +49.11pp |
| 2006-12-31 | 6.18% | $4.13 Million | $66.86 Million | -48.71pp |
| 2000-12-31 | 54.90% | $16.36 Million | $29.79 Million | +26.02pp |
| 1998-12-31 | 28.88% | $9.50 Million | $32.90 Million | -- |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more